What stage does Vision Incubate invest at?

Vision Incubate invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.

Where is Vision Incubate located?

Vision Incubate is headquartered in Kanazawa, JP.

Vision Incubate

Venture capital

Kanazawa · Pre-Seed–Growth · 9 people tracked

Also known as 株式会社ビジョンインキュベイト

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Vision Incubate focuses on backing companies born from academic research at Japanese national universities and similar institutions. Its name reflects a dual mission: 'Vision' — the dreams of researchers, the firm, and society — and 'Incubate' — supporting the return of those visions to people and society. Recent investments span deep science and technology areas including surgical-support AI, autonomous driving, bacteriophage/biotech, and oncology drug research and development.

Invests inAI & Machine Learning Biotech Deep Tech Healthtech Mobility & Transportation Sector AgnosticAsia-PacificJapan

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Growth

Kanazawa, JP

Instruments

Equity

Tracked investments

Team · 9 people

from the firm's website

Hironori Nagahira· 取締役 Chief Operating Officer

Studied at Kyoto Institute of Technology; worked on database systems and network infrastructure at Kyoto University and later medical information systems and industry-academia collaboration at Kanazawa University. Led the establishment of Vision Incubate and its VI-1 fund.

Kunio Matsumoto· 代表取締役 Chief Executive Officer

Ph.D. in science; professor at Kanazawa University's Nano Life Science Institute and vice-president for industry-academia collaboration. Founded Kringle Pharma in 2001 (listed on Tokyo Stock Exchange Mothers in 2020), developing HGF-based therapies for intractable diseases.

Mizuho Takeda· 取締役 Chief Strategy Officer

Ph.D. in science (biophysics) from Kanazawa University and Tokyo Institute of Technology. Has served as executive, founder, and investor in multiple life science and biotech ventures, with healthcare business development experience across Japan, the US, and Canada, and serves on NEDO and JST startup-support committees.

Ken Shimokawa· インベストメントマネージャー Venture Partner

Ph.D. in organic chemistry from the University of Pennsylvania. Worked in drug discovery and business development at Yamanouchi/Astellas, was managing director at Astellas Ventures (US), and became the first president of Santen Ventures, investing in 20 companies with 10 exits.

Nobutoshi Maeda· ベンチャーパートナー Venture Partner

Waseda University graduate (MBA/MOT). Worked at investment firms before founding NV Ventures in 2019 as president. Has over 20 years supporting R&D-focused, university-originated startups, and serves as an advisor to NEDO and JAEA.

Shigeji Nakaguro· ベンチャーパートナー Venture Partner

Former securities professional who worked as an incubation manager at SMRJ and an industry-academia coordinator at JAIST. In 2018 founded a general incorporated foundation for regional revitalization, promoting new-business creation and industry-academia-government-finance collaboration in the Hokuriku region and nationwide.

Fumito Takamichi· マネージャー Manager

University of Toyama economics graduate who worked at Hokkoku Bank in corporate sales and M&A. Serves as project manager for the Tech Startup HOKURIKU platform and as an associate on investment activities.

Hiromi Machii· 監査役 Auditor / Professional Venture Partner

Law/humanities graduate of Kanazawa University with extensive banking experience at Long-Term Credit Bank of Japan and foreign financial institutions. Served as auditor of JICA from 2014 to 2022 and brings governance and internal-audit expertise.

Kojiro Takagi· マネージャー Manager

Joined after working at Kanazawa University and the Ministry of Education. Serves as project manager for the Tech Startup HOKURIKU platform under the startup ecosystem co-creation program and as an associate on investment activities.

What they invest in

from 7 of 16 portfolio companies

Biotech ×6Medical Devices ×3Deep Tech ×2AI & Machine Learning ×1Digital Health ×1Healthtech ×1Mobility & Transportation ×1New Materials ×1

HQs:Japan×4

Investments · 16 tracked

founders shown can be your intro path

AMS企画株式会社ams-plan.com

AMS develops next-generation nuclear medicine technologies for Japan's market, including PET diagnostics and radiotherapeutics for precision oncology, alongside a proprietary bedside filtration system for safe radioactive waste management in hospitals.

BiotechHealthtechMedical Devices

Anaut Surganaut-surg.com

CORE Biomedicine, Inc. がん領域をはじめとする医薬品の研究・開発corebiomedicine.com

CORE Biomedicine develops precision oncology therapeutics targeting core lineage-dependent pathways in cancer, moving beyond genomic approaches to address fundamental biological programs driving tumor survival and therapy resistance.

BiotechDigital HealthMedical Devices

JURO SCIENCES株式会社

Moveez Incmoveez-inc.com

MoveEz develops mapless autonomous driving technology that operates reliably in adverse weather conditions without heavy dependence on high-precision digital maps.

AI & Machine LearningMobility & TransportationKanazawa, JP

Naoki Suganuma(CTO, Founder)Keisuke Yoneda(Co-Founder, CAIO)Eric Wei(CEO)

Sfgscisfgsci.comin

SFG Sciences is a drug discovery and development company focused on creating breakthrough therapeutics across various diseases.

Biotech

Board上村尚人エイミー・ブロイドリック

Tekmoftekmof.comin 𝕏

TEKMOF develops Metal Organic Frameworks (MOFs) using kinetic-controlled design for molecular trapping, adsorption, and molecular structure determination.

BiotechDeep TechNew MaterialsTokyo, JP

Masaki Kawano(Founder & CSO / Technical Advisor)Chiaki Tsuboi(Co-founder & CEO)Yuki Wada(Co-founder & Director (Technology))Yuji Yoshida(Director (Digital, Operation & Finance))

THE PHAGEthephage.life

Biotech company that exhibited and presented at SusHi Tech Tokyo 2026.

アナウト株式会社

Develops and sells the surgical-assist AI system EUREKA.

アナウト株式会社 (Anaut)

Develops and sells EUREKA, a surgical-support AI system.

オプティアム・バイオテクノロジーズ株式会社optieumbio.comin

Optieum develops next-generation CAR-T cell therapies using a proprietary CAR discovery platform to optimize immune cell activation for treating solid tumors and hematological malignancies.

BiotechDeep TechMedical Devices

ムービーズ

Autonomous driving startup (MoveEz) that exhibited at SusHi Tech Tokyo 2026.

株式会社FerroptoCureferroptocure.com

Biotech

株式会社キュービクス

株式会社ザ・ファージ

株式会社ムービーズ

Frequently asked questions

What stage does Vision Incubate invest at?: Vision Incubate invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
What sectors does Vision Incubate focus on?: Vision Incubate focuses on AI & Machine Learning, Biotech, Deep Tech, Healthtech, Mobility & Transportation, Sector Agnostic.
Where is Vision Incubate located?: Vision Incubate is headquartered in Kanazawa, JP.

Images

Similar investors

Khosla Ventures

Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.

$5K – $50M

Speedinvest

Speedinvest is a European venture capital firm with specialist investment teams that back companies from first check to global scale, primarily focused on seed-stage investing.

$5M – $30M

Basecamp Fund

A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.

$100K – $10M

MaRS

MaRS is a Toronto-based innovation hub and accelerator that supports Canadian startups from pre-seed funding through international expansion, offering workspace, mentorship, investor and customer connections, and sector-focused programming.

Ontario Centre of Innovation

The Ontario Centre of Innovation (OCI) is a government-partnered organization that drives economic growth in Ontario by funding and supporting the commercialization of advanced technologies, industry-academic collaborations, and early-stage ventures.

$500K